# Real-world Study of Treatment Outcomes in Chronic Inflammatory Demyelinating Polyneuropathy/Polyradiculoneuropathy (CIDP)

> **NCT06968975** · — · RECRUITING · sponsor: **Sanofi** · enrollment: 200 (estimated)

## Conditions studied

- Polyneuropathy, Inflammatory Demyelinating, Chronic

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06968975
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-04-11
- **Primary completion:** 2027-05-17
- **Final completion:** 2027-05-17
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2025-06-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06968975

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06968975, "Real-world Study of Treatment Outcomes in Chronic Inflammatory Demyelinating Polyneuropathy/Polyradiculoneuropathy (CIDP)". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT06968975. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*